Role of aspirin in primary prevention of cardiovascular disease

Role of aspirin in primary prevention of cardiovascular disease

The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the pr...

Bibliografski detalji
Glavni autori:	Patrono, C, Baigent, C
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2019

Slični predmeti

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
od: Baigent, C, i dr.
Izdano: (2003)

Low-dose aspirin for the prevention of atherothrombosis.
od: Patrono, C, i dr.
Izdano: (2005)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
od: Patrono, C, i dr.
Izdano: (2005)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
od: Patrono, C, i dr.
Izdano: (2010)

Prevention. Aspirin in primary prevention--good news and bad news.
od: Hennekens, C, i dr.
Izdano: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
od: Hennekens, C, i dr.
Izdano: (2012)

Aspirin in the primary prevention of vascular disease Reply
od: Baigent, C, i dr.
Izdano: (2009)

Aspirin in the primary prevention of vascular disease Reply
od: Baigent, C, i dr.
Izdano: (2009)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
od: Patrono, C, i dr.
Izdano: (2009)

Aspirin overutilization for the primary prevention of cardiovascular disease
od: VanWormer JJ, i dr.
Izdano: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
od: Ying Xing, i dr.
Izdano: (2019-07-01)

Aspirin for disease prevention: public policy or personal choice?
od: Baigent, C
Izdano: (2016)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
od: Eleni Giannopoulou, i dr.
Izdano: (2024-12-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
od: Mant, J, i dr.
Izdano: (2021)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
od: Price, H, i dr.
Izdano: (2009)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
od: Hennekens, C, i dr.
Izdano: (1989)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
od: Hennekens, C, i dr.
Izdano: (2006)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
od: Baigent, C, i dr.
Izdano: (2009)

Aspirin, platelet inhibition and cancer prevention
od: Paola Patrignani, i dr.
Izdano: (2018-11-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
od: Yinong Chen, i dr.
Izdano: (2021-09-01)

Aspirin for prevention of cancer and cardiovascular disease.
od: Rose, P, i dr.
Izdano: (2011)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
od: Athena L. Huang, i dr.
Izdano: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
od: Athena L. Huang, MD, i dr.
Izdano: (2023-09-01)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
od: Xie W, i dr.
Izdano: (2019-09-01)

Analysis of the Dilemma Involving Statins and Aspirin as Primary Prevention Alternatives in Cardiovascular Disease
od: Henry Sutanto
Izdano: (2017-10-01)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.
od: Inge Stegeman, i dr.
Izdano: (2015-01-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
od: L. A. Strizhakov
Izdano: (2012-04-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Izdano: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
od: Randall S Stafford, i dr.
Izdano: (2005-12-01)

2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease
od: Xiao-Ying Li, i dr.
Izdano: (2020-05-01)

Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
od: Hadar Haim-Pinhas, i dr.
Izdano: (2022-10-01)

Aspirin use for cardiovascular disease prevention in the uninsured population
od: Nina Liu, i dr.
Izdano: (2020-06-01)

Coxibs, traditional NSAIDs and cardiovascular safety post-PRECISION: What we thought we knew then and what we think we know now
od: Patrono, C, i dr.
Izdano: (2017)

Effects of aspirin for primary prevention in persons with diabetes mellitus
od: Bowman, L, i dr.
Izdano: (2018)

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
od: Alberto Aimo, i dr.
Izdano: (2020-01-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
od: Georg Gelbenegger, i dr.
Izdano: (2019-11-01)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
od: Tzeyu L. Michaud, i dr.
Izdano: (2015-12-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
od: Collins, R, i dr.
Izdano: (1996)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
od: Guillaume Marquis‐Gravel, i dr.
Izdano: (2024-02-01)

Aspirin for everyone older than 50? Against.
od: Baigent, C
Izdano: (2005)